This inventor holds 1 USPTO granted patent. Top assignee: Draxis Specialty Pharmaceuticals Inc.. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: Innovations in Brachytherapy: The Contributions of Richard J Flanagan
Introduction
Richard J Flanagan is an accomplished inventor based in Saint-Lazare, CA. He has made significant contributions to the field of medical technology, particularly in brachytherapy. His innovative work focuses on improving the transport and application of radioactive seeds used in cancer treatment.
Latest Patents
Flanagan holds a patent for "Brachytherapy seed transport devices and methods for using same." This patent describes devices, systems, and methods for transporting implants, specifically radioactive seeds contained within transparent sleeves that can be sealed at both ends. The design allows for multiple sleeves to be placed in a transfer device, which can then be secured in a canister for added protection. This entire assembly can be sterilized before shipment, ensuring safety and efficacy. Upon receipt, users can verify the loading pattern and activity of each sleeve, facilitating a seamless transfer into a brachytherapy needle.
Career Highlights
Flanagan is associated with Draxis Specialty Pharmaceuticals Inc., where he continues to contribute to advancements in medical technology. His work has been pivotal in enhancing the safety and effectiveness of brachytherapy procedures.
Collaborations
Throughout his career, Flanagan has collaborated with notable professionals in the field, including R William Riddoch and Pierre Morel. These partnerships have fostered innovation and have led to the development of cutting-edge medical solutions.
Conclusion
Richard J Flanagan's contributions to brachytherapy through his patented innovations demonstrate his commitment to improving cancer treatment methods. His work not only enhances the safety of medical procedures but also reflects the importance of collaboration in advancing healthcare technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile